AMA: Administration Decision on Medicare Part D Will Benefit Patients

| 1 Min Read

Statement attributed to:

Barbara L. McAneny, M.D.

President, American Medical Association

“Seriously ill patients who faced the prospect of new hurdles to accessing their medication can breathe a sigh of relief now that the Trump administration has discarded the proposal. The American Medical Association commends the administration for recognizing its proposal to weaken coverage for six protected drug classes under Medicare Part D had potential dangers for patient health. The AMA and other patient champions detailed the potential effects of the policy, and we’re grateful the administration listened.

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Figures and large health care icons

Geisinger CMO works to cut friction and lift care

| 7 Min Read
Judge's gavel in movement with a virtual text

Don’t open door to more frivolous medical liability lawsuits

| 5 Min Read
Client at a spa appointment

36 states lack regulatory oversight of med spas

| 6 Min Read
Physician points at tablet

After the survey: Turning physician well-being results into change

| 15 Min Read